Delivery Order SPE2DB20D1100-SPE2DB22FB4W4
- Not listed
- This federal contract award, valued at $4,369.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TOPROL XL 200 MG Tablets, with an ultimate completion date of March 14, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,025.79 firm fixed-price delivery order contract is for the supply of TOPROL XL 25 MG tablets to support military healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This contract award is for the delivery of 4,561,567,212 units of Metoprolol Succinate Extended-Release 25mg tablets to the Defense Logistics Agency (DLA). The $1,835.80 firm-fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. The IDC, which runs through November 2026, enables the government to efficiently procure a wide range of...
- This federal contract award is for the delivery of 4,560,483,611 units of Metoprolol Succinate Extended-Release 100 mg tablets in quantities of 1,000 units per bottle. The contract, valued at $1,979.28, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of April 5, 2023. The contract does not...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for $1,308.84 to provide Metoprolol Succinate Extended-Release Tablets, a cardiovascular medication, to support military healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
- The Defense Logistics Agency awarded a $514 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 tablets of TOPROL XL 25 MG. The order was placed under an existing indefinite-delivery/indefinite-quantity contract vehicle and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania by July 5, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the requested medications to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.38 firm fixed-price delivery order is for the supply of 4,560,481,760 units of Metoprolol Succinate ER 100 mg tablets. The contract has an ultimate completion date of March 29, 2023 and was awarded on March 28, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $1,503.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,565,683,361 units of Metoprolol Succinate Extended-Release 100 mg tablets. This is a firm-fixed price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain to provide a wide range of essential medical...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $4,599.81 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 8, 2024, with a completion date of November 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,255.46 firm fixed-price delivery order is for 4,564,098,481 units of the medication Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of March 28, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB22FB4W4Delivery Order
This federal contract award is for the delivery of 4,557,172,652 tablets of Toprol XL 100 mg, a cardiovascular medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award is a Delivery Order valued at $76,593.50 with a firm fixed price pricing type. The contract has an ultimate completion date of May 11, 2022 and was awarded on May 10, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs enable the efficient government procurement of essential pharmaceutical and medical commodities to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $76.6k | 5/10/22 |